New Managing Director Focused on Assisting Pharmaceutical & Medical Device Companies on Improving Compliance Program Effectiveness

Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced that Jack Tanselle has joined the Company as a managing director in its Huron Life Sciences practice. Tanselle will support pharmaceutical, medical device, and diagnostic companies and their suppliers on identification, mitigation, and management of key business, operations, and compliance risks.

“Life sciences companies face a proliferation of data, especially as it concerns the industry's numerous types of interactions with healthcare professionals, which presents both opportunities and risks," said Paul J. Silver, managing director and Huron Life Sciences practice leader. “Jack’s comprehensive experience and understanding of the entire life sciences industry value chain will bring practical solutions to clients and enhance our suite of compliance, strategy, and operations service offerings. He is an industry leader with many years of experience helping clients solve problems and improve their businesses. We are thrilled to have Jack join our team.”

Tanselle has more than 15 years of experience working with life science clients from the pharmaceutical, biotechnology, and medical device industries. His experience ranges from product and therapeutic area strategic planning to enterprise risk management and compliance program development and effectiveness. Tanselle joins Huron from Navigant Consulting Inc., where he served as managing director in Navigant’s Healthcare and Life Sciences Disputes, Regulatory, Compliance & Investigations practice. Prior to starting his career in consulting, Tanselle served as a product manager at Eli Lilly and Company.

About Huron Life Sciences

Huron Life Sciences serves the continuum of life sciences organizations, from biopharmaceutical to large multinational pharmaceutical companies to device and diagnostic manufacturers and the law and investment firms that support these organizations. Our unmatched expertise and collaborative approach enable us to deliver unique solutions that bridge the process of scientific discovery and sustainable business-model creation with strategies that reduce the risks associated with regulatory and government scrutiny. Huron Life Sciences has helped hundreds of organizations across the globe achieve financial, operational, and strategic objectives to drive innovation and, ultimately, deliver value to patients. Learn more at www.huronconsultinggroup.com/lifesciences or follow us on Twitter: @Huron.

About Huron Consulting Group

Huron Consulting Group helps clients in diverse industries improve performance, transform the enterprise, reduce costs, leverage technology, process and review large amounts of complex data, address regulatory changes, recover from distress, and stimulate growth. Our professionals employ their expertise in finance, operations, strategy, analytics, and technology to provide our clients with specialized analyses and customized advice and solutions that are tailored to address each client's particular challenges and opportunities to deliver sustainable and measurable results. The Company provides consulting services to a wide variety of both financially sound and distressed organizations, including healthcare organizations, leading academic institutions, Fortune 500 companies, governmental entities, and law firms. Huron has worked with more than 450 health systems, hospitals, and academic medical centers, more than 400 corporate general counsel, and more than 400 universities and research institutions. Learn more at www.huronconsultinggroup.com.

Huron Consulting GroupJenna Nichols, 312-880-5693jnichols@huronconsultinggroup.com

Huron Consulting (NASDAQ:HURN)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Huron Consulting Charts.
Huron Consulting (NASDAQ:HURN)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Huron Consulting Charts.